Background pattern
ELLAONE 30 mg FILM-COATED TABLET

ELLAONE 30 mg FILM-COATED TABLET

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ELLAONE 30 mg FILM-COATED TABLET

Introduction

Package Leaflet: Information for the User

ellaOne 30 mg film-coated tablet

Ulipristal acetate

Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.

Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor, pharmacist, or other healthcare professional.

  • Keep this package leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor, pharmacist, or other healthcare professional, even if they are side effects not listed in this package leaflet. See section 4.

Contents of the package leaflet:

  1. What is ellaOne and what is it used for
  2. What you need to know before taking ellaOne
  3. How to take ellaOne
  4. Possible side effects
  5. Storage of ellaOne
  6. Package contents and additional information
  • Useful information about contraception

1. What is ellaOne and what is it used for

ellaOne is an emergency contraceptive

ellaOne is a contraceptive intended to prevent pregnancy after unprotected sex or when a contraceptive method fails. For example:

  • if you have had unprotected sex;
  • if the condom used by you or your partner breaks, slips, or is not used;
  • if you did not take the contraceptive pill as recommended.

You should take the tablet as soon as possible after having unprotected sex, and no later than 5 days (120 hours) after.

This is because it is more effective if you take it as soon as possible after having unprotected sex.

This medication is suitable for any woman of childbearing age, including adolescents.

You can take the tablet at any time during your menstrual cycle.

ellaOne does not work if you are already pregnant

If you have a delayed period, you may be pregnant. If your period is delayed or you have symptoms of pregnancy (breast tenderness, morning sickness), you should consult a doctor or other healthcare professional before taking the tablet.

If you have unprotected sex after taking the tablet, it will not prevent you from becoming pregnant.

Unprotected sex can lead to pregnancy at any time during your menstrual cycle.

ellaOne should not be used as a regular contraceptive method

If you do not have a regular contraceptive method, talk to your doctor or other healthcare professional to help you choose the most suitable one for you.

How ellaOne works

ellaOne contains the active ingredient ulipristal acetate, which works by modifying the activity of the natural hormone progesterone necessary for ovulation to occur. As a result, this medication works by delaying ovulation. Emergency contraception is not effective in all cases. Of every 100 women who take this medication, approximately two will become pregnant.

This medication is a contraceptive used to prevent pregnancy from occurring. If you are already pregnant, it will not interrupt the existing pregnancy.

Emergency contraceptives do not protect against sexually transmitted infections.

Only the use of a condom can protect you from sexually transmitted infections. This medication will not protect you from HIV or any other sexually transmitted disease (e.g., chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, or syphilis). Consult a healthcare professional if this concerns you.

You will find more information about contraception at the end of this package leaflet.

2. What you need to know before taking ellaOne

Do not take ellaOne

  • if you are allergic to ulipristal acetate or any of the other ingredients of this medication (listed in section 6).

Warnings and precautions

Consult your doctor, pharmacist, or other healthcare professional before starting to take this medication

  • if your period is delayed or you have symptoms of pregnancy (breast tenderness, morning sickness), as you may already be pregnant (see section "Pregnancy, breastfeeding, and fertility");
  • if you have severe asthma;
  • if you have severe liver disease.

In all women, emergency contraception should be taken as soon as possible after having unprotected sex. There is some evidence that this medication may be less effective with increasing weight or body mass index (BMI), but these data were limited and not conclusive. Therefore, ellaOne is recommended for all women, regardless of their weight or BMI.

You are advised to consult a healthcare professional if you are concerned about any issues related to emergency contraception.

If you become pregnant despite taking this medication, it is essential that you consult your doctor. See the section "Pregnancy, breastfeeding, and fertility" for more information.

Using ellaOne with other contraceptives

This medication may temporarily reduce the effectiveness of your regular hormonal contraceptives, such as pills or patches. If you are currently using hormonal contraceptives, continue to use them as usual after taking the tablet, but make sure to use condoms every time you have sex until your next period.

Do not take ellaOne with another emergency contraceptive pill that contains levonorgestrel. Taking them together may reduce the effectiveness of this medication.

Other medications and ellaOne

Tell your doctor, pharmacist, or other healthcare professional if you are taking or have recently taken any other medication, including those obtained without a prescription or herbal remedies.

Some medications may prevent ellaOne from working effectively. If you have used any of the following medications in the last 4 weeks, ellaOne may be less effective for you. Your doctor may prescribe a different type of emergency contraception (non-hormonal), i.e., a copper intrauterine device (IUD):

  • Medications used to treat epilepsy (e.g., primidone, phenobarbital, phenytoin, fosphenytoin, carbamazepine, oxcarbazepine, and barbiturates).
  • Medications used to treat tuberculosis (e.g., rifampicin and rifabutin).
  • A treatment for HIV (ritonavir, efavirenz, nevirapine).
  • A medication for fungal infections (griseofulvin).
  • Herbal remedies containing St. John's Wort (Hypericum perforatum).

Consult your doctor or pharmacist before using ellaOne if you use (or have recently used) any of the mentioned medications.

Pregnancy, breastfeeding, and fertility

Pregnancy

Before taking this medication, if your period is delayed, talk to your doctor, pharmacist, or other healthcare professional or take a pregnancy test to ensure you are not already pregnant (see section "Warnings and precautions").

This medication is a contraceptive used to prevent pregnancy from occurring. If you are already pregnant, it will not interrupt the existing pregnancy.

If you become pregnant despite taking this medication, there is no evidence that it will affect your pregnancy. However, it is essential that you consult your doctor. As with any pregnancy, your doctor may want to check that the pregnancy is not ectopic. This is especially important if you have severe abdominal pain or bleeding or have had an ectopic pregnancy, tubal surgery, or a long-standing genital infection in the past.

If you become pregnant despite taking ellaOne, we encourage you to talk to your doctor to register your pregnancy in an official registry. You can also report the information yourself at www.hra-pregnancy-registry.com. Your information will be kept anonymous; no one will know that the information refers to you. By sharing this information, you can help other women understand the safety or risks of ellaOne during pregnancy in the future.

Breastfeeding

If you take this medication while breastfeeding, do not breastfeed your baby for the week after using this medication. We recommend that, during this week, you use a breast pump to maintain milk production but discard the expressed milk. The effect on the baby of breastfeeding in the week after taking this medication is unknown.

Fertility

This medication does not affect your future fertility. If you have unprotected sex after taking this medication, it will not prevent you from becoming pregnant. Therefore, it is essential that you use condoms until your next period.

If you want to start using or continue using a conventional contraceptive method after using this medication, you can do so, but you must also use condoms until your next period.

Driving and using machines

After taking this medication, some women experience dizziness, drowsiness, blurred vision, or loss of concentration (see section 4). If you experience these symptoms, do not drive or use machines.

ellaOne contains lactose

If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medication.

This medication contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".

3. How to take ellaOne

Follow the administration instructions for this medication contained in this package leaflet or as indicated by your doctor, pharmacist, or other healthcare professional. If you are unsure, consult your doctor or pharmacist again.

How to take the ellaOne film-coated tablet

  • Take one tablet orally as soon as possible, but no later than 5 days (120 hours) after having unprotected sex or when a contraceptive method fails. Take the tablet without delay.
  • You can take the tablet at any time during your menstrual cycle.
  • You can take the tablet at any time of day, either before, during, or after a meal.
  • If you are using one of the medications that may prevent ellaOne from working correctly (see section 2 "What you need to know before taking ellaOne") or if you have used one of these medications in the last 4 weeks, ellaOne may be less effective for you. Consult your doctor or pharmacist before using ellaOne. Your doctor may prescribe a different type of emergency contraception (non-hormonal), i.e., a copper IUD.

If you vomit after taking ellaOne

If you vomit (regurgitate) within 3 hours of taking the tablet, take another tablet as soon as possible.

If you have unprotected sex again after taking ellaOne

If you have unprotected sex after taking the tablet, it will not prevent you from becoming pregnant. After taking the tablet and until your next period, you must use condoms every time you have sex.

If your next period is delayed after taking ellaOne

After taking the tablet, it is normal for your next period to be delayed by a few days. However, if your period is delayed by more than 7 days, is shorter or longer than usual, or if you experience symptoms such as abdominal pain, breast tenderness, vomiting, or nausea, you may be pregnant. You should take a pregnancy test immediately. If you are pregnant, it is essential that you consult your doctor (see section "Pregnancy, breastfeeding, and fertility").

If you take more ellaOne than you should

No harmful effects have been reported from taking a higher dose of this medication than recommended. However, consult your doctor, pharmacist, or other healthcare professional.

If you have any further questions about the use of this medication, ask your doctor, pharmacist, or other healthcare professional.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them. Some symptoms, such as breast tenderness and abdominal pain, vomiting, and nausea, are also possible signs of pregnancy. If your period does not arrive and you experience these symptoms after taking ellaOne, you should take a pregnancy test (see section "Pregnancy, breastfeeding, and fertility").

Common side effects (may affect up to 1 in 10 patients):

  • nausea, abdominal pain or discomfort, vomiting
  • painful periods, pelvic pain, breast tenderness
  • headache, dizziness, mood changes
  • muscle pain, back pain, fatigue

Uncommon side effects (may affect up to 1 in 100 patients):

  • diarrhea, heartburn, flatulence, dry mouth
  • irregular or unusual vaginal bleeding, heavy or prolonged periods, premenstrual syndrome, vaginal irritation or discharge, decreased or increased libido
  • hot flashes
  • changes in appetite, emotional disorders, anxiety, agitation, sleep disorders, drowsiness, migraines, visual disturbances
  • flu
  • acne, skin lesions, itching
  • fever, chills, malaise

Rare side effects (may affect up to 1 in 1,000 patients):

  • genital pain or itching, pain during sex, rupture of an ovarian cyst, lighter than usual periods
  • loss of concentration, vertigo, tremors, disorientation, fainting
  • strange sensation in the eyes, red eyes, sensitivity to light
  • dry throat, taste disorders
  • allergic reactions such as rash, hives, or swelling of the face
  • feeling of thirst

Reporting side effects

If you experience any side effects, consult your pharmacist, doctor, or healthcare professional, even if they are side effects not listed in this package leaflet. You can also report them directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of ellaOne

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date stated on the carton and blister after "EXP". The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Medications should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Package Contents and Additional Information

Composition of ellaOne

  • The active ingredient is ulipristal acetate. Each film-coated tablet contains 30 milligrams of ulipristal acetate.
  • The other ingredients are:
  • Tablet core: lactose monohydrate, povidone, sodium croscarmellose, magnesium stearate.
  • Coating film: polyvinyl alcohol (E1203), macrogol (E1521), talc (E553b), titanium dioxide (E171), polysorbate 80 (E433), iron oxide yellow (E172), potassium and aluminum silicate (E555).

Appearance and Packaging of ellaOne

ellaOne is a film-coated tablet of golden color, shield-shaped (approximately 10.8 mm in diameter) and engraved with "ella" on both sides.

ellaOne is marketed in a box containing a blister pack with 1 film-coated tablet.

Marketing Authorization Holder

LABORATOIRE HRA PHARMA

200 avenue de Paris

92320 CHATILLON

France

Email: info-ella@hra-pharma.com

Manufacturer

Cenexi

17, rue de Pontoise

95520 Osny

France

Delpharm Lille S.A.S.

Parc d’activités Roubaix-Est

22, rue de Toufflers

CS 50070

59452 Lys-Lez-Lannoy

France

You can request more information about this medication by contacting the local representative of the marketing authorization holder:

België/Belgique/Belgien

Omega Pharma Belgium NV

Tel: +32 (0)9 381 04 30

Lietuva

Orivas UAB

Tel: +370 5 252 6570

Text in Bulgarian language with the name of the company MagnaPharm Bulgaria EAD and its phone number

Luxembourg/Luxemburg

Omega Pharma Belgium NV

Tel: +32 (0)9 381 04 30

Ceská republika

Akacia Group, s.r.o.

Tel: + 420-(0)220 610 491

Magyarország

Zentiva Pharma Kft.

Tel.: + 36 1 299 1058

Danmark

Perrigo Sverige AB

Tel: +46 8 59 00 29 00

Malta

Laboratoire HRA Pharma

Tel: + 33-(0)1 40 33 11 30

Deutschland

Perrigo Deutschland GmbH

+49 7032 9154 200

Nederland

Omega Pharma Nederland BV

Tel: +31 (0) 10 2211007

Eesti

Orivas OÜ

Tel: +372 639 8845

Norge

Perrigo Sverige AB

Tel: +46 8 59 00 29 00

Ελλáδα

ΒΙΑΝΕΞ Α.Ε.

Τηλ: + 30 210 8009111-120

Österreich

Perrigo Deutschland GmbH

+49 7032 9154 200

España

Perrigo España, S.A.

Tel: +34 902 889 010

Polska

Perrigo Poland Sp. z o.o.

Tel: +48 (22) 489 54 51

France

Laboratoires Omega Pharma France

Tél/Tel: + 33-(0) 1 55 48 18 00

Portugal

HRA Pharma Iberia S.L. sucursal em Portugal

Tel: +351 707 501 996

Hrvatska

Arenda d.o.o.

Tel: + 385-(0)1 644 44 80

România

Perrigo Romania S.R.L.

Tel: +40 213 150 344

Ireland

Laboratoire HRA Pharma

Tel: + 33-(0)1 40 33 11 30

Slovenija

Dr. Gorkic d.o.o.

Tel: + 386-(0)1 7590 251

Ísland

Laboratoire HRA Pharma

Sími: + 33-(0)1 40 33 11 30

Slovenská republika

Liek, s.r.o.

Tel: + 421-(0)905 667 410

Italia

HRA Pharma Italia srl, società unipersonale

Tel: + 39 06 59 60 09 87

Suomi/Finland

Perrigo Sverige AB

Tel: +46 8 59 00 29 00

Text in Greek language with contact information of a company BIANEE A.E including phone number

Sverige

Perrigo Sverige AB

Tel: +46 8 59 00 29 00

Date of Last Revision of this Leaflet:

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu/.

USEFUL INFORMATION ABOUT CONTRACEPTION

MORE ABOUT EMERGENCY CONTRACEPTION

The sooner you take emergency contraception, the more likely you are to avoid pregnancy. Emergency contraception does not affect your fertility.

Emergency contraception may delay ovulation within a given menstrual cycle, but it will not prevent you from getting pregnant if you have unprotected sex again. After taking emergency contraception and until your next period, you should use condoms every time you have sex.

MORE ABOUT REGULAR CONTRACEPTION

If you have taken emergency contraception and are not using a regular contraceptive method (or do not have a contraceptive method that suits you), consult your doctor or a family planning clinic. There are many different types of contraceptives, and you should be able to find one that is suitable for you.

Examples of regular contraceptive methods include:

Daily Methods

Contraceptive pill

Weekly or Monthly Methods

Contraceptive patch

Vaginal ring

Long-Acting Methods

Contraceptive implant

IUD (intrauterine device)

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2025 Oladoctor. All rights reserved.
VisaMastercardStripe